Recent Finacing
Recent Raise
Anagram Therapeutics is a clinical-stage biopharmaceutical company developing orally delivered enzyme therapeutics for malabsorption syndromes and nutrient metabolism disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
Create a free account to see the team members at Anagram Therapeutics.
